Investment firms Samsung launched ‘Samsung Life Science Fund 3’, a $145 million fund to invest in global biotech companies and support strategic collaborations THENA Capital closed its inaugural Fund I, at £45 million, to back UK medtech startups, anchored by the British Business Bank Investors Trent Munro appointed Venture Partner at Brandon Capital Karolina […]
The Annual BioBabraham Symposium is a joint initiative between the Babraham Institute and Babraham Research Campus in Cambridge, UK, that brings together academic and commercial stakeholders to highlight the exceptional scientific innovation taking place on campus. Across the day, the Symposium showcased an impressive range of companies, with particularly strong momentum in immunology, spanning target discovery, immunomodulation approaches and ADCs. The programme also highlighted advances in neurological […]
Hansa Biopharma’s ConfIdeS Phase 3 abstract selected for ‘What’s Hot, What’s New’ plenary at ATC 2026 Hansa Biopharma AB, announced on Thursday that the ConfIdeS Phase 3 abstract titled “Superior 1-year eGFR Among Highly Sensitized Patients Desensitized with Imlifidase Compared to Control” had been selected to be highlighted at the closing plenary session “What’s Hot, What’s New” at the American Transplant Congress (ATC) 2026, which took place in Boston on June […]
Hansa Biopharma appointed Adam Cutler as new Chief Financial Officer Hansa Biopharma AB announced the appointment of Adam Cutler as its new Chief Financial Officer (CFO) and member of the Executive Committee, effective June 22, 2026. Adam succeeds Evan Ballantyne, who has served as CFO since 2024. Evan will continue in the role until June […]
It’s now almost nine years since the first CAR-T therapies, Kymriah and Yescarta, were approved by the FDA. These therapies and others have revolutionised the treatment of certain hard-to-treat blood cancers, such as ALL and some B-cell lymphomas. There was rightly huge elation at the time. CAR-Ts were a real breakthrough, offering a lifeline – […]
